ARCHIVES

Fondaparinux Prevents DVT In Acutely III Medical Patients

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

Five Proposals Submitted In Recompetition Of FCRF Operations/Support Contract; Now Under Review

January 2, 1987

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

NCI Advised To Seek Greater Local Contribution to Construction Projects; Other changes Asked

January 28, 1977

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009